Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Thu, 16.07.2026       https://research-hub.de/companies/123fahrschule-se

123fahrschule’s preliminary H1 2026 results broadly support our full-year expectations. Revenue increased slightly to EUR 13.0m despite a declining market, while reported and adjusted EBITDA reached EUR 0.85m and EUR 1.1m, respectively. The core driving school business improved, and Foerst is expected to accelerate in H2 on stronger simulator demand. FahrerWerk added five locations through its first asset-light partnership, supporting the model’s expansion potential. Meanwhile, the Bundesrat left the reform’s key digital elements unchanged, reducing regulatory risk. With estimates unchanged, we reiterate our BUY rating and EUR 5.20 price target for the shares. The full update can be downloaded under https://research-hub.de/companies/123fahrschule-se
Thu, 16.07.2026       https://research-hub.de/companies/delivery-hero-se

Uber and Delivery Hero have signed a business combination agreement for a voluntary cash offer of EUR 41.50 per share, implying a fully diluted equity value of EUR 13.0bn. The offer is supported by both boards and is accompanied by a EUR 1.4bn carve-out of 14 overlapping markets to SSW Partners. Uber’s existing stake, additional instruments and irrevocable tender commitments would take its position already above 53%. Closing is expected in H2 2027 and remains subject to regulatory approvals. We raise our price target to EUR 41.50 and recommend tendering. SELL. The full update can be downloaded under https://research-hub.de/companies/delivery-hero-se
Thu, 16.07.2026       https://research-hub.de/companies/basf-se

BASF’s Q2 prelims showed a strong pricing-led earnings beat, supported by sustained volumes and supply-chain dislocation rather than a broad-based recovery in underlying demand. While the segment mix remained uneven and higher raw-material prices continued to weigh on cash conversion, management’s guidance upgrade confirms stronger near-term earnings momentum. BASF’s resilient supply setup should allow it to keep benefiting if disruptions persist, although weaker demand and working-capital pressure remain key risks. Following the recent sell-off, we view the risk/reward as more attractive and upgrade the shares from HOLD to BUY, with a slightly revised price target of EUR 55.00. The full update can be downloaded under https://research-hub.de/companies/basf-se
Thu, 16.07.2026       https://research-hub.de/companies/circus-se

Circus has announced a substantial downward revision to its FY26 guidance, slashing revenue expectations to EUR 5.2m (previously EUR 44m to EUR 55m) and widening its projected EBITDA loss to c. EUR -17m (previously a loss of EUR -6m to EUR -8m). According to management, the cut is driven by operational bottlenecks in the supply chain and maintenance, which have pushed planned rollouts into FY27. At this stage, it remains difficult to determine whether these challenges represent structural scalability issues or merely temporary setbacks. Acknowledging the company's inherently high degree of uncertainty and a flatter growth trajectory, we sharply downgrade our estimates and reduce our price target to EUR 8.40 (previously EUR 46.00). However, given the significant long-term upside if these operational hurdles are cleared, we issue a Spec. BUY recommendation (previously BUY) for investors with a high risk tolerance. The full update can be downloaded under https://research-hub.de/companies/circus-se
Wed, 15.07.2026       LAIQON AG

Company Name: LAIQON AG ISIN: DE000A12UP29   Reason for the research: Update Recommendation: BUY from: 15.07.2026 Target price: €8.70 Target price on sight of: 12 months Last rating change: - Analyst: Christian Orquera First Berlin Equity Research has published a research update on LAIQON AG (ISIN: DE000A12UP29). Analyst Ch [ … ]
Wed, 15.07.2026       Pentixapharm Holding AG

Company Name: Pentixapharm Holding AG ISIN: DE000A40AEG0   Reason for the research: Initiation Recommendation: BUY Target price: EUR 7.2 Target price on sight of: 12 months Last rating change: Analyst: Simon Keller A major diagnostic market opening. Pentixapharm is the way to play it. Enter PentixaFor: a simple, non-invasive an [ … ]
Wed, 15.07.2026       https://research-hub.de/companies/traton-se

Traton’s preliminary Q2 figures point to a clear improvement in adjusted profitability, with Group adj. EBIT coming in well above expectations and International Motors returning to positive territory. However, the release included only a limited number of KPIs and focused solely on adjusted operating metrics. More importantly, the strong earnings performance was not matched by cash generation, as net cash flow remained negative and significantly below consensus. This divergence may reflect non-cash, one-off tariff-related receivables recognition and working-capital movements, but the limited disclosure does not yet allow for a firm conclusion. We therefore leave our estimates unchanged and await the full Q2 and H1 results on 23 July for better visibility on reported earnings, cash conversion and margin sustainability. Our broader investment thesis remains unchanged, with cyclical weakness and rising structural competition still key concerns. We maintain our SELL rating and EUR 23.00 PT. The full update can be downloaded under https://research-hub.de/companies/traton-se
Wed, 15.07.2026       https://research-hub.de/companies/pyramid-ag

Pyramid AG reported strong preliminary H1 2026 results, showing sales of EUR 40.3m (+10% yoy) and EBITDA of EUR 1.9m. Momentum was exceptionally strong in Q2, where revenues grew 28% qoq to EUR 22.6m and the EBITDA margin reached 7.5% (vs 1.1% in Q1). Supported by an annualized order intake run-rate of over EUR 100m, the operational turnaround is taking shape. While consolidated results and cash conversion remain to be seen, the operational trend and the recently secured balance sheet stability support a constructive outlook. We reiterate our BUY rating and PT of EUR 3.30. The full update can be downloaded under https://research-hub.de/companies/pyramid-ag
Wed, 15.07.2026       https://research-hub.de/companies/vossloh-ag

Vossloh announced preliminary Q2 2026 results showing strong revenue growth, supported by the consolidation of Sateba, while profitability came under pressure from integration effects and higher procurement and logistics costs. Management also lowered its 2026 guidance, reflecting weaker call-offs under framework agreements, project delays into 2027 and limited cost pass-through. However, the underlying investment case remains intact. Order intake continued to grow strongly and the order book reached a new record, providing solid visibility for the coming years. We therefore reduce our FY 2026 estimates to around the midpoint of the new guidance and lower our medium-term margin assumptions. Despite this, we still expect Vossloh to achieve its 2030 targets, supported by structural growth in rail infrastructure spending. Following the recent share-price sell-off, we see an attractive entry point. We reiterate our BUY rating but lower our PT to EUR 90.00 from EUR 100.00. The full update can be downloaded under https://research-hub.de/companies/vossloh-ag
Tue, 14.07.2026       https://research-hub.de/companies/mhp-hotel-ag

MHP Hotel AG (MHP) has secured a long-term lease agreement for a new ~180-room Marriott Autograph Collection hotel in the heart of Düsseldorf, expanding its total portfolio to 16 properties in operation or in active pipeline. Developed in partnership with Midstad and scheduled to open by 2029 within the iconic, historic Carsch-Haus building ensemble, this project is expected to generate stabilized annual revenue of over EUR 20m. The transaction hits the sweet spot of a polarizing DACH hotel market, where the premium and luxury tiers heavily outpace the budget segment. By repositioning scarce, culturally significant inner-city architecture, MHP can command premium average daily rates and achieve high occupancy. Furthermore, as MHP continues to scale its footprint across premier metropolitan hubs, it is well-positioned to exploit significant operational cluster synergies, leading us to confirm our BUY recommendation with a price target of EUR 3.00. The full update can be downloaded under https://research-hub.de/companies/mhp-hotel-ag

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Wednesday, 07.10.2026, Calendar Week 41, 280th day of the year, 85 days remaining until EoY.